Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
ImExHS Limited ( (AU:IME) ) has shared an update.
IMEXHS Limited has successfully completed its Share Purchase Plan (SPP), following a $1.5 million placement to institutional investors and a conditional $1.0 million placement to its directors. The SPP resulted in the issuance of 294,287 new shares at $0.35 each, aligning with the placement price, and these shares will rank equally with existing shares. This financial maneuver is expected to bolster IMEXHS’s market position and support its ongoing operations, potentially benefiting stakeholders by enhancing the company’s capital structure.
The most recent analyst rating on (AU:IME) stock is a Buy with a A$1.15 price target. To see the full list of analyst forecasts on ImExHS Limited stock, see the AU:IME Stock Forecast page.
More about ImExHS Limited
IMEXHS Limited is an innovative provider of medical imaging software and radiology services operating in 18 countries, including Colombia, the US, and Australia. Founded in 2012, the company offers cloud-based, vendor-neutral, and zero-footprint software solutions such as Picture Archiving and Communications System (PACS), Radiology Information System (RIS), Cardiology Information System (CIS), and Anatomical Pathology Laboratory Information System (APLIS). These products are designed to enhance productivity, reduce costs, and improve patient outcomes.
Average Trading Volume: 24,338
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$17.15M
For a thorough assessment of IME stock, go to TipRanks’ Stock Analysis page.